The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure.

A Vanderbilt University-led research team has discovered a molecular “rheostat” in the brain’s appetite control center that may provide new insights into obesity, which is at epidemic levels in this country.

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

New findings suggest that misfolded proteins accumulate in the heart atria, particularly in patients with hypertension, and may contribute to atrial heart disease.

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.

When it comes to taking care of our hearts, there is a big divide between what we should do and what we actually do, a new multi-institution study reports.